000			01513 a2200361 4500
005			20250513122152.0
264		0	_c19970827
008			199708s 0 0 eng d
022			_a0006-2952
024	7		_a10.1016/s0006-2952(96)00882-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aSen, N
245	0	0	_aActivation of protein kinase C by 1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-phenyl]-3-py rid ine carboxylic acid methyl ester (Bay K 8644), a calcium channel agonist, in alveolar type II cells. _h[electronic resource]
260			_bBiochemical pharmacology _cMay 1997
300			_a1307-13 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_a3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester _xpharmacology
650	0	4	_aAnimals
650	0	4	_aCalcium Channel Agonists _xpharmacology
650	0	4	_aCalcium Channels _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEnzyme Activation
650	0	4	_aNifedipine _xpharmacology
650	0	4	_aPhosphatidylcholines _xmetabolism
650	0	4	_aProtein Kinase C _xmetabolism
650	0	4	_aPulmonary Alveoli _xdrug effects
650	0	4	_aRats
700	1		_aWu, A M
700	1		_aSpitzer, A R
700	1		_aChander, A
773	0		_tBiochemical pharmacology _gvol. 53 _gno. 9 _gp. 1307-13
856	4	0	_uhttps://doi.org/10.1016/s0006-2952(96)00882-9 _zAvailable from publisher's website
999			_c9195055 _d9195055